MAPK Signaling
Activated MAPKs transduce the phosphorylation and activation of MAPK-activated protein kinases (MAPKAPKs), e.g. RSK, MSK, or MNK family, and MK2/3/5. There are three main MAPK families, signal-regulated kinase 1 and 2 (Erk1/2 or p44/42), the c-Jun N-terminal kinases 1-3 (JNK1-3)/ stress activated protein kinases (SAPK1A, 1B, 1C), the p38 isoforms (p38α, β, γ, and δ). ERK signaling is involved in cell division, migration and survival. p38 MAPK and JNK/SAPK pathways are activated by cellular stress. The p38 MAPK pathway regulates cell motility, transcription, and chromatin remodeling. JNK/SAPK signaling affects apoptosis and inflammation. Dysregulation of MAPK pathway results in tumorgenesis and other pathological conditions.
- B6674 AnisomycinTarget: p38|JNK|SAPKSummary: JNK agonist, potent and specific
- B6921 SKF 86002 dihydrochlorideSummary: p38 MAP kinase inhibitor
- B6962 CMPD-1Target: Microtubules/Tubulins|MK2Summary: inhibitor of p38α-mediated MK2a phosphorylation
- B7140 JX 401Summary: p38α inhibitor
- B7215 EO 1428Summary: p38α and p38β2 inhibitor
- B7276 XRP44XSummary: Ras-Net (Elk-3) pathway inhibitor
- B7307 L-779,450Summary: Raf kinase inhibitor
- B7321 TCS JNK 6oTarget: JNKSummary: JNK inhibitor
- B7444 SU 3327Summary: JNK inhibitor
- B7450 SX 011Summary: p38α inhibitor